Skip to Content

WPI 2265 (Acitretin 22.5 mg)

Pill with imprint WPI 2265 is Brown, Capsule-shape and has been identified as Acitretin 22.5 mg. It is supplied by Actavis Pharma, Inc..

Acitretin is used in the treatment of psoriasis; psoriatic arthritis; pityriasis rubra pilaris and belongs to the drug class antipsoriatics. Not for use in pregnancy. Acitretin 22.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 2265

Acitretin

Imprint:
WPI 2265
Strength:
22.5 mg
Color:
Brown
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antipsoriatics
Pregnancy Category:
X - Not for use in pregnancy
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Actavis Pharma, Inc.
National Drug Code (NDC):
00591-2265

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide